AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Critical Illness Weakness Outside the Intensive Care Unit.

Recruitingn/aAges any - anyAllIstituto Clinico Humanitas
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

When people become seriously ill, their bodies can be affected in many ways beyond the original disease. One well-known complication in patients treated in intensive care units (ICUs) is the development of severe muscle weakness caused by damage to muscles and nerves. This condition is called critical illness-related weakness and includes disorders of the nerves (neuropathy), the muscles (myopathy), or both. These problems can make it difficult for patients to move, walk, or even breathe independently, and recovery can take months or longer. So far, most research on this type of weakness has focused on patients who were treated in ICUs. However, many hospitalized patients outside the ICU-such as those admitted to internal medicine wards or semi-intensive care units-can also experience severe infections, organ failure, inflammation, prolonged bed rest, and metabolic stress. These are the

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Age โ‰ฅ 18 years * Hospitalization for acute illness in a non-ICU unit * For the critical illness cohort: presence of organ failure defined as a SOFA score โ‰ฅ 2 at admission or an increase (ฮ”SOFA) โ‰ฅ 2 during hospitalization * For the control cohort: SOFA score \< 2 throughout hospitalization * Ability to provide written informed consent Exclusion Criteria: * History of peripheral neuropathy, myopathy, or other neuromuscular disorders (e.g., myasthenia gravis) * Conditions affecting the lower limbs that prevent electrophysiological testing * Delirium with agitation preventing clinical evaluation * Coma or inability to assess muscle strength
๐Ÿ’Š

What it tests

  • No Intervention: Observational Cohort
๐Ÿ“

Where

1 site
Humanitas Research Institute
Rozzano, Italy
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy